Oragenics Inc. Files 8-K Report
Ticker: OGEN · Form: 8-K · Filed: May 16, 2024 · CIK: 1174940
Sentiment: neutral
Topics: sec-filing, 8-k, financial-statements
TL;DR
Oragenics filed an 8-K, mostly financial docs. Nothing major yet.
AI Summary
On May 16, 2024, Oragenics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update rather than a major event. No specific financial figures or significant business developments were detailed in the provided excerpt.
Why It Matters
This filing indicates Oragenics, Inc. is fulfilling its reporting obligations with the SEC, providing updates on financial statements and exhibits.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for financial statements and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- May 16, 2024 (date) — Date of Report
- 1990 Main Street Suite 750 Sarasota , FL 34236 (address) — Principal executive offices
- 813 - 286-7900 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Oragenics, Inc.?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of May 16, 2024.
What is Oragenics, Inc.'s state of incorporation?
Oragenics, Inc. is incorporated in Florida (FL).
What is the IRS Employer Identification Number for Oragenics, Inc.?
The IRS Employer Identification Number for Oragenics, Inc. is 59-3410522.
What is the address of Oragenics, Inc.'s principal executive offices?
The address of Oragenics, Inc.'s principal executive offices is 1990 Main Street, Suite 750, Sarasota, FL 34236.
What is the SEC file number for Oragenics, Inc.?
The SEC file number for Oragenics, Inc. is 001-32188.
Filing Stats: 430 words · 2 min read · ~1 pages · Grade level 11 · Accepted 2024-05-16 08:00:22
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 16KB
- 0001493152-24-020128.txt ( ) — 230KB
- ogen-20240516.xsd (EX-101.SCH) — 3KB
- ogen-20240516_lab.xml (EX-101.LAB) — 33KB
- ogen-20240516_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this May 16, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer